- Home
- IOVA vs ALRM Comparison
IOVA vs ALRM Comparison
Compare IOVA & ALRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOVA
- ALRM
- Stock Information
- Founded
- IOVA 2007
- ALRM 2000
- Country
- IOVA United States
- ALRM United States
- Employees
- IOVA N/A
- ALRM N/A
- Industry
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- ALRM Computer Software: Prepackaged Software
- Sector
- IOVA Health Care
- ALRM Technology
- Exchange
- IOVA Nasdaq
- ALRM Nasdaq
- Market Cap
- IOVA 2.6B
- ALRM 3.1B
- IPO Year
- IOVA N/A
- ALRM 2015
- Fundamental
- Price
- IOVA $5.82
- ALRM $60.57
- Analyst Decision
- IOVA Strong Buy
- ALRM Buy
- Analyst Count
- IOVA 9
- ALRM 6
- Target Price
- IOVA $23.06
- ALRM $65.33
- AVG Volume (30 Days)
- IOVA 7.2M
- ALRM 291.5K
- Earning Date
- IOVA 02-26-2025
- ALRM 02-20-2025
- Dividend Yield
- IOVA N/A
- ALRM N/A
- EPS Growth
- IOVA N/A
- ALRM 80.16
- EPS
- IOVA N/A
- ALRM 2.31
- Revenue
- IOVA $90,858,000.00
- ALRM $923,824,000.00
- Revenue This Year
- IOVA $13,803.28
- ALRM $8.17
- Revenue Next Year
- IOVA $167.55
- ALRM $4.58
- P/E Ratio
- IOVA N/A
- ALRM $26.17
- Revenue Growth
- IOVA 12751.20
- ALRM 6.98
- 52 Week Low
- IOVA $5.05
- ALRM $51.87
- 52 Week High
- IOVA $18.33
- ALRM $77.29
- Technical
- Relative Strength Index (RSI)
- IOVA 49.38
- ALRM 36.87
- Support Level
- IOVA $5.44
- ALRM $61.64
- Resistance Level
- IOVA $5.80
- ALRM $61.25
- Average True Range (ATR)
- IOVA 0.31
- ALRM 1.61
- MACD
- IOVA 0.09
- ALRM -0.31
- Stochastic Oscillator
- IOVA 82.43
- ALRM 2.85
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About ALRM Alarm.com Holdings Inc.
Alarm.com Holdings Inc has two reportable segments: Alarm.com & Other. The Alarm.com segment represents the cloud-based Software platforms for intelligently connected property & related solutions. The other segment is focused on researching, developing & offering residential & commercial automation solutions & energy management products & services in adjacent markets. The majority of revenue is from the Alarm.com segment. The platform allows home & business owners to secure their properties and automate & control an array of connected devices. SaaS & license fees from service providers, who resell these services & pay Alarm.com a monthly subscription, are the sources of revenue for the firm. The majority of revenue is generated in the United States & Canada.